Xypho Accel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Xypho accel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Xypho Accel Today - Breaking & Trending Today
Poseida Therapeutics shares were up 18% to $2.86 after the company said it entered into a research collaboration and license agreement with Astellas Pharma s Xyphos Biosciences. ....
Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
San Francisco-based Xyphos Biosciences Inc. is pooling technology platforms with Boston’s Kelonia Therapeutics Inc. in a novel immuno-oncology (I-O) drug discovery deal that could fetch more than $800 million. Xyphos and Kelonia will collaborate to develop a maximum of two in vivo CAR T-cell therapy programs, utilizing both Kelonia’s in vivo gene placement system called iGPS and Xyphos’ Accel technology platform. ....